Start with what FDA says about these products
The FDA's patient guidance on regenerative medicine (content current as of 2024) is the most useful reference for an American comparing clinics abroad, even though it doesn't cover treatment outside the US. Its key points:
- The only FDA-approved stem cell products are blood-forming stem cells from umbilical cord blood, approved for disorders that affect blood production.
- Products sold for orthopedic problems (osteoarthritis, back or joint pain), neurological conditions (MS, ALS, Parkinson's, Alzheimer's, stroke), autism, eye disease, heart and lung disease, chronic pain or fatigue aren't approved for those uses.
- FDA has received reports of blindness, tumor formation and infections. It also lists blood infections, immune reactions, unintended tissue growth, and contamination from processing or untested donor material as risks.
- Being charged for these products outside an FDA-overseen clinical trial is, in FDA's words, a warning sign. A listing on ClinicalTrials.gov doesn't by itself mean a product is approved or legally marketed.
This doesn't mean every clinic abroad is fraudulent, or that no patient benefits. It means the burden of proof sits with the clinic. The CDC Yellow Book (2026) adds that drugs and biologic products abroad may be less regulated, and that legal recourse if something goes wrong may be more limited than in the US.
Compare the product before the country
"Stem cell therapy" covers very different products. The type you're offered matters more than where it's given:
| What clinics may offer | Where the cells come from | FDA status for the conditions usually marketed | Questions it raises |
|---|---|---|---|
| Bone-marrow aspirate concentrate | Your own bone marrow, processed the same day | Not approved for orthopedic, neurological or other conditions in FDA's list | What evidence exists for my condition? How many cells are actually in the injection? |
| Stromal vascular fraction (from fat) | Your own fat, processed the same day | Named by FDA among products that require approval; not approved for these uses | Is processing done in a controlled lab? What are the infection precautions? |
| Culture-expanded cells | Your own or donor cells, grown in a lab over days or weeks | Not approved for these uses | Which lab, under what quality standards? Can you show batch testing? |
| Umbilical cord, Wharton's jelly, amniotic or placental products | Donor birth tissue | FDA names these and states they aren't approved for these uses (cord-blood products are approved only for blood-forming disorders) | How was the donor screened? What testing is done for infections? |
| Exosomes | Cell-derived particles, often from donor cells | FDA names exosomes among products that need approval | What exactly is being injected, and how is it standardized? |
Mexico, Panama and Colombia: what to compare
Each country has its own regulator and its own rules on cell-based products. Those rules change, and clinics often describe their status loosely ("government-approved," "licensed," "certified"). We couldn't verify a current, authoritative summary of each country's framework, so we don't characterize them here. Ask each clinic to name the authority and the exact type of authorization, then check it with that authority yourself.
| Comparison point | What to ask a clinic in any of the three countries | A reassuring answer | A red flag |
|---|---|---|---|
| Legal status | "Which national authority authorizes this specific product for my condition, and under what reference number?" | A named authority and a reference you can look up | "Government approved" with no specifics |
| Trial registration | "Is this a registered clinical trial? What's the registry ID, and who oversees it?" | A trial ID with an ethics committee, and no charge for the investigational product | You pay full price for "trial" participation |
| Evidence | "What published, peer-reviewed results support this for my condition?" | Specific citations you can read, with honest limitations | Testimonials, videos or "thousands of patients treated" |
| Lab and processing | "Where are the cells processed, and to what quality standards?" | A named lab with documented testing | Vague answers, or refusal to say |
| Physician | "Who administers the treatment, and what's their specialty and licence?" | A verifiable licence and a relevant specialty | Staff whose credentials you can't verify |
| Complications | "What happens if I get an infection or another reaction after I fly home?" | A written plan and records you can give your doctor | No plan beyond "it's very safe" |
Logistics that do differ
Once a clinic passes those checks, the practical differences are like those for other travel. Mexico is closest for most Americans. Panama and Colombia are short same-hemisphere flights from US hubs. All three work mainly in Spanish, so ask for consent forms and records in English. CDC advises bringing home overseas records in English and sharing them with your doctors. Because many stem cell procedures are injections rather than surgery, the waiting time before flying is usually short. Still, ask whether the treatment includes any procedure that changes that, such as a bone-marrow harvest, liposuction for fat-derived cells, or a spinal injection.
Also ask what the follow-up looks like. A clinic confident in its treatment should be able to describe how it measures your progress over the following months, and how it would share those measurements with your doctor at home.
Protect your existing care
The biggest hidden cost of an unproven treatment can be what it displaces. CDC warns, in the context of cancer care abroad, about delaying or forgoing proven treatment. The same logic applies to any serious condition. Before you travel:
- Tell your own specialist what you're considering, and ask what you might lose by pausing or changing current treatment.
- Don't stop prescribed medicines because a clinic suggests it, without your own doctor's agreement.
- Find out whether your condition has an active, legitimate clinical trial nearer home. These typically don't charge for the investigational product.
Our guide to reading clinical evidence shows how to judge the studies a clinic sends you. For the cost side, see stem cell therapy cost in the US vs Colombia, and for the wider legal picture, how patient protections differ by country.
How to read a clinic's success claims
Stem cell clinics often quote improvement percentages or patient-satisfaction figures. Before you rely on any of them, ask:
- Compared with what? Without a control group, improvement can reflect natural ups and downs, other treatments, or the placebo effect, which can be strong for pain.
- Measured how, and by whom? A validated score recorded by an independent assessor means more than a follow-up phone survey by the clinic.
- Over what period? Short-term relief after an injection doesn't show lasting benefit.
- Published where? Results in a peer-reviewed journal can be scrutinized. Figures on a website can't.
If something goes wrong
A fever, spreading redness, new neurological symptoms or severe pain after a cell injection needs prompt medical care. Tell the treating doctors exactly what product you received. In the US, you can report adverse events to FDA through its MedWatch program.
The Takeaway
Between Mexico, Panama and Colombia, the country is the least important variable. Compare the product, its legal status for your condition, the evidence and the lab. Then compare logistics, and only for clinics that pass those checks.
Frequently asked questions
Are stem cell treatments in Mexico, Panama or Colombia FDA-approved?
FDA doesn't approve treatments given abroad. In the US, FDA has approved stem cell products only for blood-forming disorders, and it states that products marketed for orthopedic, neurological and many other conditions aren't approved for those uses.
Which of the three countries regulates stem cells best?
We don't rank them, because we couldn't verify a current, authoritative comparison. Ask each clinic which authority authorizes its specific product, then confirm the authorization with that authority directly.
Is paying for a stem cell "clinical trial" normal?
FDA describes being charged for these products outside an FDA-overseen trial as a warning sign. Legitimate trials usually don't charge for the investigational product. Ask for the trial registry ID and the ethics committee.
What risks has FDA reported?
FDA has received reports of blindness, tumor formation and infections. It also lists blood infections, immune reactions and contamination among the risks of unapproved regenerative products.
What should I bring home after treatment abroad?
A written record, in English, of exactly what product you received, its source, dose and injection site, the processing lab, and any medicines given. Share it with your doctor at home.